STOCKHOLDERS’ EQUITY (DEFICIT) (Tables)

3 Months Ended

Mar. 31, 2024

Accumulated Other Comprehensive Income (Loss) [Line Items]

SCHEDULE OF RESERVED SHARES

Exercise of issued and future grants of stock options	755,715
Conversion of convertible debt	4,895,869
Exercise of stock warrants	4,798,105
Total	10,449,689

SCHEDULE OF STOCK OPTION ACTIVITY

The following represents a summary of the options granted under the 2020 Plan to employees and non-employee service providers that are outstanding at March 31, 2024, and changes during the three-month period then ended:

	Shares		Weighted– Average Exercise Price		Range of Exercise Price		Weighted– Average Remaining Life (Years)
Total outstanding – December 31, 2023		398,924	$	35.21	$	5.14 — $51.30		7.06
Granted		—		—		—		—
Expired		—		—		—		—
Forfeited		—		—		—		—
Total outstanding – March 31, 2024		398,924	$	35.21	$	5.14 — $51.30		6.81
Exercisable (vested)		321,751	$	41.89	$	5.14 — $51.30		6.52
Non-Exercisable (non-vested)		77,173	$	7.33	$	5.14 — $32.90		8.04

The following represents a summary of the options granted to employees and non-employee service providers that were outstanding at March 31, 2023, and changes during the three-month period then ended:

	Shares			Weighted– Average Exercise Price		Range of Exercise Price		Weighted– Average Remaining Life (Years)
Total outstanding – December 31, 2022		608,012		$	35.02	$	5.14 - $51.30		8.09
Granted		—			—		—		—
Expired		—			—		—		—
Forfeited		(55,451	)		33.05	$	5.14 — $51.30		—
Total outstanding – March 31, 2023		552,561		$	35.22	$	5.14 — $51.30		7.82
Exercisable (vested)		290,438		$	46.17	$	10.50 — $51.30		7.35
Non-Exercisable (non-vested)		262,123		$	23.08	$	5.14 — $51.30		8.40

SCHEDULE OF SHARE-BASED COMPENSATION EXPENSE

The Company recorded stock-based compensation expense and classified it in the condensed consolidated statements of operations as follows:

	March 31,		March 31,
	2024		2023
General and administrative	$	34,014	$	203,722
Research and development		24,637		48,504
Total	$	58,651	$	252,226

Compensatory Warrant Activity [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

SCHEDULE OF NON COMPENSATORY WARRANT ACTIVITY

The following table summarizes the activity in the common stock equity classified compensatory warrants for the three months ended March 31, 2024:

	Common Stock
	Shares			Weighted– Average Exercise Price		Range of Exercise Price		Weighted– Average Remaining Life (Years)
Total outstanding – December 31, 2023		119,046		$	10.69	$	0.73—$25.40		1.25
Exercised		—
Expired		(7,261	)	$	20.66	$	20.26
Forfeited		—
Total outstanding – March 31, 2024		111,785		$	9.40	$	0.26—$25.40		1.07
Exercisable		111,785		$	9.40	$	0.26—$25.40		1.07
Non-Exercisable		—			—		—		—

The following table summarizes the activity in the common stock equity classified compensatory warrants for the three months ended March 31, 2023:

	Common Stock
	Shares		Weighted– Average Exercise Price		Range of Exercise Price		Weighted– Average Remaining Life (Years)
Total outstanding – December 31, 2022		179,046	$	9.12	$	1.32 — $25.40		1.73
Exercised		—
Expired		—
Forfeited		—
Total outstanding – March 31, 2023		179,046	$	9.12	$	1.32 — $25.40		1.48
Exercisable		179,046	$	9.12	$	1.32 — $25.40		1.48
Non-Exercisable		—		—		—		—

Non Compensatory Warrant Activity [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

SCHEDULE OF NON COMPENSATORY WARRANT ACTIVITY

The following table summarizes the noncompensatory equity classified warrant activity for the three months ended March 31, 2024:

	Common Stock
	Shares			Weighted– Average Exercise Price		Range of Exercise Price		Weighted– Average Remaining Life (Years)
Total outstanding – December 31, 2023		2,507,050		$	0.73	$	0.73		4.47
Granted		900,016		$	0.26	$	0.26		4.92
Exercised		—
Expired		—
Forfeited		(2	)	$	0.26	$	0.26
Total outstanding – March 31, 2024		3,407,064		$	0.26	$	0.26		4.41
Exercisable		3,407,064		$	0.26	$	0.26		4.41
Non-Exercisable		—			—		—		—

The following table summarizes the noncompensatory equity classified warrant activity for the three months ended March 31, 2023:

	Common Stock
	Shares			Weighted– Average Exercise Price		Range of Exercise Price		Weighted– Average Remaining Life (Years)
Total outstanding – December 31, 2022		547,003		$	19.76		1.32 - 20.00		0.33
Granted		—
Exercised		—
Expired		(320,853	)	$	20.00	$	20.00
Forfeited		—
Total outstanding – March 31, 2023		226,150		$	19.42	$	1.32 — $20.00
Exercisable		226,150		$	19.42	$	1.32 — $20.00		0.46
Non-Exercisable		—		$	—	$	—		—